Compile Data Set for Download or QSAR
Report error Found 40 Enz. Inhib. hit(s) with all data for entry = 11407
TargetCannabinoid receptor 2(Human)
Centrexion Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 295696BDBM295696(US10112934, Example 5 | US10570125, Example 5 | US...)
Affinity DataEC50:  0.230nMAssay Description:CHO cells expressing human CB2R (Euroscreen) were plated at a density of 10,000 cells per well in 384 well plates and incubated overnight at 37° C. A...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2023
Entry Details
US Patent

TargetCannabinoid receptor 2(Human)
Centrexion Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 295694BDBM295694(Example 46 in WO2010147792 | US10570125, Example 4...)
Affinity DataEC50:  0.270nMAssay Description:CHO cells expressing human CB2R (Euroscreen) were plated at a density of 10,000 cells per well in 384 well plates and incubated overnight at 37° C. A...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2023
Entry Details
US Patent

TargetCannabinoid receptor 2(Human)
Centrexion Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 295693BDBM295693(US10112934, Example 4 | US10570125, Example 4 | US...)
Affinity DataEC50:  0.360nMAssay Description:CHO cells expressing human CB2R (Euroscreen) were plated at a density of 10,000 cells per well in 384 well plates and incubated overnight at 37° C. A...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2023
Entry Details
US Patent

TargetCannabinoid receptor 2(Human)
Centrexion Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 295695BDBM295695(Example 7 in WO2010147792 | US11084810, Example 7 ...)
Affinity DataEC50:  0.680nMAssay Description:CHO cells expressing human CB2R (Euroscreen) were plated at a density of 10,000 cells per well in 384 well plates and incubated overnight at 37° C. A...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2023
Entry Details
US Patent

TargetCannabinoid receptor 2(Human)
Centrexion Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 295697BDBM295697(Example 47 in WO2010147792 | US10570125, Example 4...)
Affinity DataEC50:  0.850nMAssay Description:CHO cells expressing human CB2R (Euroscreen) were plated at a density of 10,000 cells per well in 384 well plates and incubated overnight at 37° C. A...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2023
Entry Details
US Patent

TargetCannabinoid receptor 2(Human)
Centrexion Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 50042659BDBM50042659(CHEMBL3353870 | Example 190 in WO2010077836 | US10...)
Affinity DataEC50:  2.80nMAssay Description:CHO cells expressing human CB2R (Euroscreen) were plated at a density of 10,000 cells per well in 384 well plates and incubated overnight at 37° C. A...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2023
Entry Details
US Patent

TargetCannabinoid receptor 2(Human)
Centrexion Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 295691BDBM295691(Example 38 in WO2010036630 | US10570125, Example 3...)
Affinity DataEC50:  3.10nMAssay Description:CHO cells expressing human CB2R (Euroscreen) were plated at a density of 10,000 cells per well in 384 well plates and incubated overnight at 37° C. A...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2023
Entry Details
US Patent

TargetCannabinoid receptor 2(Human)
Centrexion Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 295702BDBM295702(US10112934, Example 8 | US10570125, Example 8 | US...)
Affinity DataEC50:  4.30nMAssay Description:CHO cells expressing human CB2R (Euroscreen) were plated at a density of 10,000 cells per well in 384 well plates and incubated overnight at 37° C. A...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2023
Entry Details
US Patent

TargetCannabinoid receptor 2(Human)
Centrexion Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 295701BDBM295701(Example 30 in WO2010147792 | US10570125, Example 3...)
Affinity DataEC50:  5.40nMAssay Description:CHO cells expressing human CB2R (Euroscreen) were plated at a density of 10,000 cells per well in 384 well plates and incubated overnight at 37° C. A...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2023
Entry Details
US Patent

TargetCannabinoid receptor 2(Human)
Centrexion Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 295689BDBM295689(US10112934, Example 3 | US10570125, Example 3 | US...)
Affinity DataEC50:  8nMAssay Description:CHO cells expressing human CB2R (Euroscreen) were plated at a density of 10,000 cells per well in 384 well plates and incubated overnight at 37° C. A...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2023
Entry Details
US Patent

TargetCannabinoid receptor 2(Human)
Centrexion Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 295698BDBM295698(US10112934, Example 6 | US10570125, Example 6 | US...)
Affinity DataEC50:  11nMAssay Description:CHO cells expressing human CB2R (Euroscreen) were plated at a density of 10,000 cells per well in 384 well plates and incubated overnight at 37° C. A...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2023
Entry Details
US Patent

TargetCannabinoid receptor 2(Human)
Centrexion Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 50006447BDBM50006447(CHEMBL3234702 | Example 2 in WO2010036630 | US1108...)
Affinity DataEC50:  11nMAssay Description:CHO cells expressing human CB2R (Euroscreen) were plated at a density of 10,000 cells per well in 384 well plates and incubated overnight at 37° C. A...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2023
Entry Details
US Patent

TargetCannabinoid receptor 2(Human)
Centrexion Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 435493BDBM435493(US10570125, Example 7 | US11084810, Example 7 in W...)
Affinity DataEC50:  15nMAssay Description:CHO cells expressing human CB2R (Euroscreen) were plated at a density of 10,000 cells per well in 384 well plates and incubated overnight at 37° C. A...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2023
Entry Details
US Patent

TargetCannabinoid receptor 2(Human)
Centrexion Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 435491BDBM435491(US10570125, Example 1 | US11084810, Example 1 | US...)
Affinity DataEC50:  18nMAssay Description:CHO cells expressing human CB2R (Euroscreen) were plated at a density of 10,000 cells per well in 384 well plates and incubated overnight at 37° C. A...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2023
Entry Details
US Patent

TargetCannabinoid receptor 2(Human)
Centrexion Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 295700BDBM295700(US10112934, Example 7 | US11084810, Example 7 | US...)
Affinity DataEC50:  25nMAssay Description:CHO cells expressing human CB2R (Euroscreen) were plated at a density of 10,000 cells per well in 384 well plates and incubated overnight at 37° C. A...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2023
Entry Details
US Patent

TargetCannabinoid receptor 2(Human)
Centrexion Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 295688BDBM295688(Example 17 in WO2010036630 | US10570125, Example 1...)
Affinity DataEC50:  30nMAssay Description:CHO cells expressing human CB2R (Euroscreen) were plated at a density of 10,000 cells per well in 384 well plates and incubated overnight at 37° C. A...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2023
Entry Details
US Patent

TargetCannabinoid receptor 2(Human)
Centrexion Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 435502BDBM435502(US10570125, Example 134 | US11084810, Example 134 ...)
Affinity DataEC50:  49nMAssay Description:CHO cells expressing human CB2R (Euroscreen) were plated at a density of 10,000 cells per well in 384 well plates and incubated overnight at 37° C. A...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2023
Entry Details
US Patent

TargetCannabinoid receptor 2(Human)
Centrexion Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 295674BDBM295674(Example 1 in WO2010036630 | US11084810, Example 1 ...)
Affinity DataEC50:  88nMAssay Description:CHO cells expressing human CB2R (Euroscreen) were plated at a density of 10,000 cells per well in 384 well plates and incubated overnight at 37° C. A...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2023
Entry Details
US Patent

TargetCannabinoid receptor 2(Human)
Centrexion Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 295673BDBM295673(US10112934, Example 2 | US10570125, Example 2 | US...)
Affinity DataEC50:  104nMAssay Description:CHO cells expressing human CB2R (Euroscreen) were plated at a density of 10,000 cells per well in 384 well plates and incubated overnight at 37° C. A...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2023
Entry Details
US Patent

TargetCannabinoid receptor 2(Human)
Centrexion Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 295692BDBM295692(Example 133 in WO2010036630 | US10570125, Example ...)
Affinity DataEC50:  140nMAssay Description:CHO cells expressing human CB2R (Euroscreen) were plated at a density of 10,000 cells per well in 384 well plates and incubated overnight at 37° C. A...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2023
Entry Details
US Patent

TargetCannabinoid receptor 1(Human)
Centrexion Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 295694BDBM295694(Example 46 in WO2010147792 | US10570125, Example 4...)
Affinity DataIC50: 923nMAssay Description:CHO cells expressing human CB1R (Euroscreen) were plated at a density of 10,000 cells per well in 384 well plates and incubated overnight at 37° C. A...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2023
Entry Details
US Patent

TargetCannabinoid receptor 1(Human)
Centrexion Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 295696BDBM295696(US10112934, Example 5 | US10570125, Example 5 | US...)
Affinity DataIC50: 2.50E+3nMAssay Description:CHO cells expressing human CB1R (Euroscreen) were plated at a density of 10,000 cells per well in 384 well plates and incubated overnight at 37° C. A...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2023
Entry Details
US Patent

TargetCannabinoid receptor 1(Human)
Centrexion Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 295697BDBM295697(Example 47 in WO2010147792 | US10570125, Example 4...)
Affinity DataIC50: 3.10E+3nMAssay Description:CHO cells expressing human CB1R (Euroscreen) were plated at a density of 10,000 cells per well in 384 well plates and incubated overnight at 37° C. A...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2023
Entry Details
US Patent

TargetCannabinoid receptor 1(Human)
Centrexion Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 50042659BDBM50042659(CHEMBL3353870 | Example 190 in WO2010077836 | US10...)
Affinity DataIC50: 7.87E+3nMAssay Description:CHO cells expressing human CB1R (Euroscreen) were plated at a density of 10,000 cells per well in 384 well plates and incubated overnight at 37° C. A...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2023
Entry Details
US Patent

TargetCannabinoid receptor 1(Human)
Centrexion Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 295695BDBM295695(Example 7 in WO2010147792 | US11084810, Example 7 ...)
Affinity DataIC50: 8.08E+3nMAssay Description:CHO cells expressing human CB1R (Euroscreen) were plated at a density of 10,000 cells per well in 384 well plates and incubated overnight at 37° C. A...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2023
Entry Details
US Patent

TargetCannabinoid receptor 1(Human)
Centrexion Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 295688BDBM295688(Example 17 in WO2010036630 | US10570125, Example 1...)
Affinity DataIC50: 8.60E+3nMAssay Description:CHO cells expressing human CB1R (Euroscreen) were plated at a density of 10,000 cells per well in 384 well plates and incubated overnight at 37° C. A...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2023
Entry Details
US Patent

TargetCannabinoid receptor 1(Human)
Centrexion Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 435502BDBM435502(US10570125, Example 134 | US11084810, Example 134 ...)
Affinity DataIC50: 2.60E+4nMAssay Description:CHO cells expressing human CB1R (Euroscreen) were plated at a density of 10,000 cells per well in 384 well plates and incubated overnight at 37° C. A...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2023
Entry Details
US Patent

TargetCannabinoid receptor 1(Human)
Centrexion Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 435493BDBM435493(US10570125, Example 7 | US11084810, Example 7 in W...)
Affinity DataIC50: 2.80E+4nMAssay Description:CHO cells expressing human CB1R (Euroscreen) were plated at a density of 10,000 cells per well in 384 well plates and incubated overnight at 37° C. A...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2023
Entry Details
US Patent

TargetCannabinoid receptor 1(Human)
Centrexion Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 295693BDBM295693(US10112934, Example 4 | US10570125, Example 4 | US...)
Affinity DataIC50: 3.94E+4nMAssay Description:CHO cells expressing human CB1R (Euroscreen) were plated at a density of 10,000 cells per well in 384 well plates and incubated overnight at 37° C. A...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2023
Entry Details
US Patent

TargetCannabinoid receptor 1(Human)
Centrexion Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 295674BDBM295674(Example 1 in WO2010036630 | US11084810, Example 1 ...)
Affinity DataIC50: 5.00E+4nMAssay Description:CHO cells expressing human CB1R (Euroscreen) were plated at a density of 10,000 cells per well in 384 well plates and incubated overnight at 37° C. A...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2023
Entry Details
US Patent

TargetCannabinoid receptor 1(Human)
Centrexion Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 295691BDBM295691(Example 38 in WO2010036630 | US10570125, Example 3...)
Affinity DataIC50: 5.00E+4nMAssay Description:CHO cells expressing human CB1R (Euroscreen) were plated at a density of 10,000 cells per well in 384 well plates and incubated overnight at 37° C. A...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2023
Entry Details
US Patent

TargetCannabinoid receptor 1(Human)
Centrexion Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 295702BDBM295702(US10112934, Example 8 | US10570125, Example 8 | US...)
Affinity DataIC50: 6.90E+4nMAssay Description:CHO cells expressing human CB1R (Euroscreen) were plated at a density of 10,000 cells per well in 384 well plates and incubated overnight at 37° C. A...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2023
Entry Details
US Patent

TargetCannabinoid receptor 1(Human)
Centrexion Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 295698BDBM295698(US10112934, Example 6 | US10570125, Example 6 | US...)
Affinity DataIC50: 8.70E+4nMAssay Description:CHO cells expressing human CB1R (Euroscreen) were plated at a density of 10,000 cells per well in 384 well plates and incubated overnight at 37° C. A...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2023
Entry Details
US Patent

TargetCannabinoid receptor 1(Human)
Centrexion Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 435491BDBM435491(US10570125, Example 1 | US11084810, Example 1 | US...)
Affinity DataIC50: 1.04E+5nMAssay Description:CHO cells expressing human CB1R (Euroscreen) were plated at a density of 10,000 cells per well in 384 well plates and incubated overnight at 37° C. A...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2023
Entry Details
US Patent

TargetCannabinoid receptor 1(Human)
Centrexion Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 295701BDBM295701(Example 30 in WO2010147792 | US10570125, Example 3...)
Affinity DataIC50: 1.20E+5nMAssay Description:CHO cells expressing human CB1R (Euroscreen) were plated at a density of 10,000 cells per well in 384 well plates and incubated overnight at 37° C. A...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2023
Entry Details
US Patent

TargetCannabinoid receptor 1(Human)
Centrexion Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 50006447BDBM50006447(CHEMBL3234702 | Example 2 in WO2010036630 | US1108...)
Affinity DataIC50: 1.50E+5nMAssay Description:CHO cells expressing human CB1R (Euroscreen) were plated at a density of 10,000 cells per well in 384 well plates and incubated overnight at 37° C. A...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2023
Entry Details
US Patent

TargetCannabinoid receptor 1(Human)
Centrexion Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 295673BDBM295673(US10112934, Example 2 | US10570125, Example 2 | US...)
Affinity DataIC50: 2.00E+5nMAssay Description:CHO cells expressing human CB1R (Euroscreen) were plated at a density of 10,000 cells per well in 384 well plates and incubated overnight at 37° C. A...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2023
Entry Details
US Patent

TargetCannabinoid receptor 1(Human)
Centrexion Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 295689BDBM295689(US10112934, Example 3 | US10570125, Example 3 | US...)
Affinity DataIC50: 2.00E+5nMAssay Description:CHO cells expressing human CB1R (Euroscreen) were plated at a density of 10,000 cells per well in 384 well plates and incubated overnight at 37° C. A...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2023
Entry Details
US Patent

TargetCannabinoid receptor 1(Human)
Centrexion Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 295700BDBM295700(US10112934, Example 7 | US11084810, Example 7 | US...)
Affinity DataIC50: 2.00E+5nMAssay Description:CHO cells expressing human CB1R (Euroscreen) were plated at a density of 10,000 cells per well in 384 well plates and incubated overnight at 37° C. A...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2023
Entry Details
US Patent

TargetCannabinoid receptor 1(Human)
Centrexion Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 295692BDBM295692(Example 133 in WO2010036630 | US10570125, Example ...)
Affinity DataIC50: 2.00E+5nMAssay Description:CHO cells expressing human CB1R (Euroscreen) were plated at a density of 10,000 cells per well in 384 well plates and incubated overnight at 37° C. A...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2023
Entry Details
US Patent